|1.||Jones, Ronald N: 4 articles (03/2007 - 07/2005)|
|2.||Dowzicky, Michael J: 4 articles (03/2007 - 07/2005)|
|3.||Stilwell, Matthew G: 3 articles (07/2005 - 07/2005)|
|4.||Fritsche, Thomas R: 3 articles (07/2005 - 07/2005)|
|5.||Sader, Helio S: 3 articles (07/2005 - 07/2005)|
|6.||Loh, Evan: 2 articles (09/2005 - 05/2004)|
|7.||Bassis, Christine M: 1 article (03/2015)|
|8.||Schumacher, Cassie A: 1 article (03/2015)|
|9.||Young, Vincent B: 1 article (03/2015)|
|10.||Seekatz, Anna M: 1 article (03/2015)|
11/01/2006 - "Tigecycline, a first-in-class expanded glycylcycline antimicrobial agent, has demonstrated efficacy in the treatment of complicated skin and skin structure infections (cSSSI) and complicated intra-abdominal (cIAI) infections. "
06/01/2014 - "Tigecycline, a novel intravenously administered glycylcycline antibiotic, currently plays a key role in the management of complicated multiorganism infections. "
12/01/2011 - "Tigecycline (Tygacil, Wyeth) is a relatively new FDA and EMEA approved glycylcycline antimicrobial with an expanded broad-spectrum activity against pathogens involved in complicated skin and skin structure infections. "
02/01/2010 - "The effectiveness of a new first-in-class antibiotic, tigecycline (glycylcycline), was evaluated during the early dissemination (1 week), early immune (3 weeks), or late persistent (4 months) phases of Borrelia burgdorferi infection in C3H mice. "
01/01/2010 - "Tigecycline, a first-in-class broad-spectrum glycylcycline antibiotic, has broad-spectrum in vitro activity against bacteria commonly encountered in complicated intra-abdominal infections (cIAIs), including aerobic and facultative Gram-positive and Gram-negative bacteria and anaerobic bacteria. "
10/01/2000 - "These results show a preferential distribution of glycylcycline in the lungs and potent in vivo bactericidal activity in PRSP pneumonia."
01/01/2009 - "Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness in hospitalized CAP patients. "
01/01/2014 - "Tigecycline is a broad-spectrum, first-in-class glycylcycline antibiotic currently used to treat complicated skin and intra-abdominal infections, as well as community-acquired pneumonia. "
06/01/2013 - "Tigecycline, a new glycylcycline antimicrobial agent, is indicated for the treatment of complicated skin structure infection (cSSTI), intra-abdominal infection (cIAI) and community acquired pneumonia. "
10/01/2000 - "Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia."
11/01/2000 - "Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis."
01/01/2003 - "The activity of tigecycline (GAR-936), a novel glycylcycline, was investigated in vitro and in experimental endocarditis due to the susceptible Enterococcus faecalis JH2-2 strain, its VanA type transconjugant BM4316, and a clinical VanA type strain, E. "
11/01/2000 - "The glycylcycline was more efficacious at a lower administered dose in the rat model of endocarditis than was vancomycin. "
11/01/2000 - "GAR-936, a novel glycylcycline, was investigated with a rat model of experimental endocarditis. "
|4.||Wounds and Injuries (Trauma)
|5.||Soft Tissue Infections
07/01/2005 - "The antimicrobial activity of tigecycline, a novel glycylcycline, was evaluated against 5289 bacterial isolates recovered from hospitalized patients with skin and soft tissue infections during 2000-2004. "
03/01/2015 - "The glycylcycline antibiotic tigecycline was approved in 2005 for the treatment of complicated skin and soft tissue infections and complicated intra-abdominal infections. "
12/01/2008 - "Tigecycline, a new glycylcycline with an expanded broad spectrum of in vitro activity, was recently approved for the treatment of complicated skin and soft tissue infections (cSSTIs) and complicated intra-abdominal infections (cIAIs). "
|10.||RNA (Ribonucleic Acid)